Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+၀.၄၇%
၁,၀၆၇.၃၆
+၄.၉၆
+၀.၄၇%
၁,၀၆၂.၄၀၁,၀၆၄.၁၄၁,၀၇၁.၉၉၁,၀၆၁.၀၂
SIXC
Communications
SIXC
Communications
SIXC
-၀.၅၄%
၆၀၃.၄၈
-၃.၂၆
-၀.၅၄%
၆၀၆.၇၄၆၀၆.၇၄၆၀၉.၈၄၆၀၂.၃၃
SIXE
Energy
SIXE
Energy
SIXE
+၀.၅၄%
၁,၂၄၄.၉၃
+၆.၇၂
+၀.၅၄%
၁,၂၃၈.၂၁၁,၂၃၆.၆၀၁,၂၄၇.၇၄၁,၂၃၂.၁၀
SIXI
Industrials
SIXI
Industrials
SIXI
+၀.၆၈%
၁,၇၃၀.၃၈
+၁၁.၇၇
+၀.၆၈%
၁,၇၁၈.၆၁၁,၇၂၃.၂၃၁,၇၄၁.၄၈၁,၇၁၇.၄၇
SIXM
Financials
SIXM
Financials
SIXM
+၀.၃၃%
၆၃၉.၄၇
+၂.၁၀
+၀.၃၃%
၆၃၇.၃၇၆၃၈.၂၇၆၄၂.၃၀၆၃၈.၂၇
SIXR
Staples
SIXR
Staples
SIXR
+၀.၁၆%
၈၅၄.၉၅
+၁.၃၆
+၀.၁၆%
၈၅၃.၅၉၈၅၄.၀၅၈၅၈.၁၉၈၅၁.၃၄
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+၀.၁၁%
၂၁၈.၅၆
+၀.၂၃
+၀.၁၁%
၂၁၈.၃၃၂၁၈.၃၃၂၁၉.၇၃၂၁၇.၁၅
SIXT
Technology
SIXT
Technology
SIXT
+၁.၀၂%
၃,၆၃၁.၅၉
+၃၆.၇၈
+၁.၀၂%
၃,၅၉၄.၈၁၃,၆၂၀.၁၀၃,၆၅၇.၄၇၃,၆၁၅.၃၄
SIXU
Utilities
SIXU
Utilities
SIXU
+၀.၈၀%
၉၁၅.၇၇
+၇.၂၃
+၀.၈၀%
၉၀၈.၅၄၉၀၉.၅၀၉၁၇.၃၅၉၀၇.၀၇
SIXV
Health care
SIXV
Health care
SIXV
+၁.၁၉%
၁,၅၁၂.၈၁
+၁၇.၈၁
+၁.၁၉%
၁,၄၉၅.၀၀၁,၄၉၉.၆၁၁,၅၁၇.၁၀၁,၄၉၉.၆၁
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၄၁%
၂,၄၀၈.၂၁
+၉.၉၀
+၀.၄၁%
၂,၃၉၈.၃၁၂,၄၀၆.၈၂၂,၄၂၁.၈၀၂,၄၀၄.၂၂
IMRX:NASDAQ
Immuneering Corp
၅.၃၉ US$
+၃.၂၆%
(+၀.၁၇) 1D
၅.၃၅ US$
-၀.၇၄% (-၀.၀၄၀)
After hours
Closed: မေ ၂၂, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
၅.၉၉ US$
High
၆.၈၉ US$
Low
၅.၂၉ US$
Mkt. cap
၃၄.၈၇ ကုဋေ
Avg. vol.
၇.၇၃ သိန်း
Volume
၁.၀၂ ကုဋေ
52-wk high
၁၀.၀၈ US$
52-wk low
၁.၄၂ US$
EPS
-၁.၁၇ US$
Beta
၀.၃၇
Shares outstanding
၆.၄၇ ကုဋေ
No. of employees
၅၅
News stories
From sources across the web
StocksToTrade
StocksToTrade
·
ပြီးခဲ့သည့် ၁၆ နာရီ
IMRX Jumps As Immuneering Extends Cash Runway And Trial Pipeline
Timothy Sykes
Timothy Sykes
·
ပြီးခဲ့သည့် ၁၆ နာရီ
IMRX Jumps As Immuneering Touts Atebimetinib Pipeline Momentum
Quiver Quantitative
Quiver Quantitative
·
ပြီးခဲ့သည့် ၂၁ နာရီ
$IMRX stock is up 31% today. Here's what we see in our data.
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Immuneering stock jumps on pancreatic cancer trial data
About Immuneering Corp
CEO-
Employees၅၅
Founded၂၀၀၈
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၀၅ ကုဋေ
၁.၀၉ ကုဋေ
၉.၂၅ သန်း
၁.၀၆ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၃၀ သန်း
၄.၅၁ သန်း
၄.၄၉ သန်း
၄.၆၈ သန်း
Operating expense
၁.၄၈ ကုဋေ
၁.၅၄ ကုဋေ
၁.၃၈ ကုဋေ
၁.၅၃ ကုဋေ
Total operating expenses
၁.၄၈ ကုဋေ
၁.၅၄ ကုဋေ
၁.၃၈ ကုဋေ
၁.၅၃ ကုဋေ
Operating income
-၁.၄၈ ကုဋေ
-၁.၅၄ ကုဋေ
-၁.၃၈ ကုဋေ
-၁.၅၃ ကုဋေ
Other non operating income
-
-
၁.၅၆ သိန်း
၅.၁၄ သိန်း
EBT including unusual items
-၁.၄၄ ကုဋေ
-၁.၅၀ ကုဋေ
-၁.၁၆ ကုဋေ
-၁.၃၅ ကုဋေ
EBT excluding unusual items
-၁.၄၄ ကုဋေ
-၁.၅၀ ကုဋေ
-၁.၁၇ ကုဋေ
-၁.၃၅ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၄၄ ကုဋေ
-၁.၅၀ ကုဋေ
-၁.၁၆ ကုဋေ
-၁.၃၅ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၄၀
-၀.၃၈
-၀.၁၈
-၀.၂၁
Interest and investment income
၃.၂၄ သိန်း
၄.၁၆ သိန်း
၁.၈၆ သန်း
၁.၃၆ သန်း
Interest expense
-
-
-
-
Net interest expenses
၃.၂၄ သိန်း
၄.၁၆ သိန်း
၁.၈၆ သန်း
၁.၃၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၄၇ ကုဋေ
-၁.၅၃ ကုဋေ
-၁.၃၇ ကုဋေ
-၁.၅၂ ကုဋေ
Gain or loss from assets sale
-
-
၂.၀၉ ထောင်
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more